For the first time, Health Canada has approved a new drug that targets the underlying cause of early-onset Alzheimer's disease. As health reporter Katherine Ward explains, doctors say this marks a ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

TORONTO — Health Canada has authorized a drug shown to slow the progression of Alzheimer's disease. Lecanemab is the first ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

The annual “Walk to End Alzheimer’s” was one of five scheduled to be held across Mississippi this year. Hub City walkers ...

The Society of the Four Arts in Palm Beach announced its 2025-26 season lineup. Exhibitions will feature works from French ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

A Southport cancer survivor and a Florida man fighting Alzheimer's are among inspiring athletes competing in Saturday's ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.